| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 50 |
| 1 | PANTOPRAZOLE | 44 |
| 2 | UPADACITINIB | 36 |
| 3 | PREDNISOLONE | 32 |
| 4 | PREDNISOLONE ORAL | 32 |
| 5 | PREDNISOLONE ORAL SOLUTION | 32 |
| 6 | TOCILIZUMAB | 31 |
| 7 | CELECOXIB | 29 |
| 8 | DEXAMETHASONE | 24 |
| 9 | DEXAMETHASONE 1.5 MG | 24 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ISRADIPINE | 8 | 0.0143 |
| 1 | BARICITINIB | 23 | 0.0075 |
| 2 | OLUTASIDENIB | 1 | 0.0035 |
| 3 | BREXUCABTAGENE AUTOLEUCEL | 5 | 0.0023 |
| 4 | CAMPHOR, CAPSAICIN, MENTHOL | 1 | 0.0019 |
| 5 | ADALIMUMAB-RYVK | 2 | 0.0018 |
| 6 | MENTHOL, UNSPECIFIED FORM | 1 | 0.0016 |
| 7 | ACYCLOVIR SODIUM | 2 | 0.0016 |
| 8 | MIRIKIZUMAB-MRKZ | 1 | 0.0011 |
| 9 | SACCHAROMYCES CEREVISIAE | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 124 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 65 |
| 2 | Janus Kinase Inhibitor [EPC] | 64 |
| 3 | Tumor Necrosis Factor Blocker [EPC] | 38 |
| 4 | Interleukin-6 Receptor Antagonist [EPC] | 35 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 31 |
| 6 | Kinase Inhibitor [EPC] | 26 |
| 7 | Alkylating Drug [EPC] | 24 |
| 8 | Factor Xa Inhibitor [EPC] | 20 |
| 9 | Interleukin-17A Antagonist [EPC] | 20 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 11 | 0.0008 |
| 2 | Interleukin-17A Antagonist [EPC] | 20 | 0.0005 |
| 3 | Uric Acid-specific Enzyme [EPC] | 2 | 0.0005 |
| 4 | CD38-directed Cytolytic Antibody [EPC] | 3 | 0.0005 |
| 5 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 6 | CD19-directed Chimeric Antigen Receptor [EPC] | 5 | 0.0005 |
| 7 | Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] | 3 | 0.0005 |
| 8 | Non-Standardized Fungal Allergenic Extract [EPC] | 1 | 0.0005 |
| 9 | Neonatal Fc Receptor Blocker [EPC] | 2 | 0.0005 |